PreclinicalSciencesAnimalHealthDivisionChargeSept2012APPROVED

Preclinical Sciences & Animal Health Division (PSAHD) – September 2012
Terms of Reference/Charge/Functions
Committee Charge: to provide a platform to explore: use of animal models in pre-clinical
studies; interspecies differences in drug absorption, pharmacokinetics, and target site drug
delivery; and all matters relating to the animal health industry. The Committee should:















Continuously review and expand the scope of PSAHD by identifying new or existing
PSAHD areas that are not represented and developing avenues that will encourage
interest and contribution.
Seek cost-effective means to promote awareness and visibility of the PSAHD track in the
CRS.
Seek opportunities inside and outside CRS to provide education on CR technologies and
applications.
Seek opportunities to bring outside interests into CRS where they can contribute and
develop a better understanding of CRS.
Establish/re-establish university connections to encourage PSAHD interest and activity
among young scientists.
Optimize/maximize offerings at the Annual Meeting to encourage interest and provide a
maximum return on investment for attendees.
Maintain global representation on the committee to best reach the global audience.
Maintain comprehensive PSAHD representation on the committee to reach all PSAHD
industries.
Establish active connections to local CRS PSAHD chapters to gain an understanding of
their interests and identify potential mutually beneficial interactions.
By April 2013, provide the Board with a plan for activities of the Division for the coming
12 months. In developing this plan, seek input from the Board of Scientific Advisors
(BSA), the Translational & Regulatory Committee (T&R), the Products and Services
Committee (P&S) and the Annual Meeting Committee (AMC).
On request, provide input to the BSA to help it meet its role in identifying emerging
issues and trends in the Division's speciality area.
On request, provide input to the T&R to help it meet its role in identifying translational
and regulatory issues of importance to the Division's speciality area.
On request, provide input to the P&S to help it meet its role in identifying novel products
and services in the Division's specialty area.
On request, provide input to the AMC to help it meet its role in identifying themes for the
annual science meetings.
On request, provide input to the AMPC to help it meet its role in planning an Annual
Meeting.

In April each year, provide the Board with a report of activities of the previous 12
months, noting the success or otherwise of the activities and providing a work program
and resource budget (if required) for the following 12 months.
Membership
Name
Committee Term*
Notes
Michael Rathbone
Marilyn Martinez
July 19, 2012July 19, 2012-
Chair**
Chair
Deputy Chair
Anette Mullertz
Barry Moore
Cyril Desevauz
David Brayden
Peter Cheifetz
Sarah Hook
Sevda Senel
Terry Bowersock
Thierry Vandamme
Tim McCaffery
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
July 19, 2012-July 24, 2013
Michael Rathbone
Megan Pagel
July 19, 2012-July 24, 2013
Board Liaison***
Staff Liaison****
*Members (except Board Liaison – see below) are normally elected for a 3 year period.
**The Chair will normally have served at least one year as an ordinary member of the Committee, before
becoming the Chair. As soon as practicable after becoming Chair, and in consultation with the Board
Liaison and the President-elect, the Chair will identify a Deputy Chair who will succeed him/her.
***The Board Liaison is appointed by the Board for a period of one year. Function – see Board Liaison
Job Description.
****The CRS staff member provides support and guidance to ensure the successful execution of
committee goals and tasks.